Solnica Bogdan, Naskalski Jerzy W, Sieradzki Jacek
Department of Clinical Biochemistry, Collegium Medicum Jagiellonian University, ul. Kopernika 15b, 31-501, Krakow, Poland.
Clin Chim Acta. 2003 May;331(1-2):29-35. doi: 10.1016/s0009-8981(03)00079-2.
Glucometry is an essential part of diabetes treatment, but so far, no standard quality control procedure verifying blood glucose meter results is available. In this study, we evaluated the analytical performance of eight glucose meters: GX and Esprit (Bayer Diagn.), MediSense Card Sensor, ExacTech (MediSense) with strips Selfcare (Cambridge Diagn), One Touch Basic, One Touch II, One Touch Profile (Lifescan) and Glucotrend (Boehringer Mannheim/Roche).
The evaluation included within-run imprecision, linearity, comparison with the laboratory method and calculation of differences between individual glucometers.
Within-run imprecision ranged from 1.5% to 4.5%, linearity assessed as the correlation between measured and calculated glucose concentrations yielded r(2) values from 0.97 to 0.981. Analytical bias of glucose concentration values obtained by the glucometry amounted from 0.14% to 16.9% of values measured by the laboratory method. Bias higher than 5% was found for One Touch Basic, II and Profile meters (however, glucose concentrations in plasma obtained by the laboratory method One Touch meters showed analytical bias from 3.0% to 8.8%). The regression analysis yielded slope values from 0.77 to 1.09 and r(2) values from 0.86 to 0.98. The best correlations with the laboratory method were found for One Touch Basic, II Profile, Glucotrend and Esprit meters. The calculated differences between the individual glucose meters can constitute 0.02-1.49 mmol/l (0.96-26.9%) at glucose concentration 5.55 mmol/l, and 0.16-4.16 mmol/l (0.96-24.96%) at glucose concentration 16.67 mmol/l. Error grid analyses have shown that Glucometers One Touch Basic and One Touch Profile yielded all results in zone A (acceptable). The remaining glucometers yielded 1-7% of results in zones B (insignificant errors), C or D (lack of detection and treatment).
All studied glucometers had both small deviation from laboratory reference values (<10%) and high concurrence with results obtained by the laboratory method.
血糖仪检测是糖尿病治疗的重要组成部分,但目前尚无用于验证血糖仪检测结果的标准质量控制程序。在本研究中,我们评估了8款血糖仪的分析性能:GX和Esprit(拜耳诊断公司)、MediSense Card Sensor、ExacTech(MediSense)以及配套的Selfcare试纸(剑桥诊断公司)、One Touch Basic、One Touch II、One Touch Profile(强生公司)和Glucotrend(勃林格殷格翰/罗氏公司)。
评估内容包括批内不精密度、线性、与实验室方法的比较以及各血糖仪之间差异的计算。
批内不精密度范围为1.5%至4.5%,以测量的葡萄糖浓度与计算的葡萄糖浓度之间的相关性评估线性,得出的r(2)值范围为0.97至0.981。血糖仪检测获得的葡萄糖浓度值的分析偏差占实验室方法测量值的0.14%至16.9%。One Touch Basic、II和Profile血糖仪的偏差高于5%(不过,通过实验室方法在血浆中测得的One Touch血糖仪的葡萄糖浓度显示分析偏差为3.0%至8.8%)。回归分析得出的斜率值范围为0.77至1.09,r(2)值范围为0.86至0.98。One Touch Basic、II Profile、Glucotrend和Esprit血糖仪与实验室方法的相关性最佳。在葡萄糖浓度为5.55 mmol/l时,各血糖仪之间计算出的差异可达0.02 - 1.49 mmol/l(0.96 - 26.9%),在葡萄糖浓度为16.67 mmol/l时,差异为0.16 - 4.16 mmol/l(0.96 - 24.96%)。误差网格分析表明,One Touch Basic和One Touch Profile血糖仪的所有结果均在A区(可接受)。其余血糖仪有1%至7%的结果在B区(微小误差)、C区或D区(检测和治疗缺失)。
所有研究的血糖仪与实验室参考值的偏差均较小(<10%),且与实验室方法获得的结果高度一致。